Somatic Symptom Disorders in Patients With Myocardial Bridge (EARLY-MYO-SSS-CN)

Sponsor
RenJi Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04664387
Collaborator
(none)
1,394
1
42.3
33

Study Details

Study Description

Brief Summary

The purpose of this study was to investigate the prevalence of physical and mental disorder in the population of patients with myocardial bridge and to describe the relationship between clinical features and the occurrence of somatic disorder.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: coronary angiography

Detailed Description

Myocardial bridge (MB), a congenital cardiac anomaly, is an unignored contribution to chest pain. Patients with MB often complain about chest discomfort more serious than the degree of vessel compression. The symptoms are also often inconsistence with the degree of coronary stenosis. Reports suggested that patients with MB may companioned with depression and anxiety. Moreover, patients with MB often have other systemic complaints including stomach pain, pain on the back, ear blockage, et al. Investigators assume that somatic symptom disorder (SSD) may play a part in aggregating the severity of symptoms. In order to screen SSD, investigators previously developed the Somatic Symptom Scale-China (SSS-CN) questionnaire. It is a somatic and psychological symptom scale which was developed based on the DSM-5 to assess a combination of psychological, behavioral and somatic symptoms. It is designed to assess the presence and severity of the symptoms. Investigators have validated its reliability and validity in a previous study. The purpose of this study was to investigate the prevalence of physical and mental disorder in the population of patients with MB and to describe the relationship between clinical features and the occurrence of somatic disorder.

Study Design

Study Type:
Observational
Actual Enrollment :
1394 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
EARLY Assessment of Somatic Symptom Disorder in Patients With MYOcardial Bridge by Somatic Symptom Scale China (SSS-CN)
Actual Study Start Date :
Oct 30, 2016
Actual Primary Completion Date :
May 8, 2020
Actual Study Completion Date :
May 8, 2020

Arms and Interventions

Arm Intervention/Treatment
patients with myocardial bridge

patients who underwent coronary angiography and was diagnosed as myocardial bridge

Diagnostic Test: coronary angiography
A coronary angiography is a test to find out if there is stenosis in coronary artery.

patients without myocardial bridge

patients who underwent coronary angiography and was diagnosed as without myocardial bridge

Diagnostic Test: coronary angiography
A coronary angiography is a test to find out if there is stenosis in coronary artery.

Outcome Measures

Primary Outcome Measures

  1. the score of Somatic Symptom Scale-China (SSS-CN) [within 24 hours before the coronary angiography.]

    to compare the score of Somatic Symptom Scale-China questionnaire between patients with and without myocardial bridge. SSS-CN is a self-administered questionnaire with 20 items and scoring 1, 2, 3, 4 to each item. The total score is from 20 to 80. The higher the score is, the higher frequency that the symptoms presented.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • cardiology inpatients with the age older than 18, complained with chest discomfort and was suspected with coronary artery disease.

  • undertook Somatic Symptom Scale-China (SSS-CN) questionnaire, Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires.

  • underwent cardiac angiography.

  • agree to participate.

Exclusion Criteria:
  • patients who are in emergency or unconsciousness.

  • patients who refuse to participate or with unfinished questionnaire.

  • the questionnaires were undertook after the angiography.

  • patients who have previously been confirmed to have mental disorders, mental retardation or dementia, cannot finish questionnaires

  • patients who currently take anti-anxiety or anti-depression agents.

  • patients who have been confirmed to have heart diseases other than coronary vascular disease.

  • patients who have been previously confirmed to have other physical diseases.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Renji Hospital Shanghai China 200127

Sponsors and Collaborators

  • RenJi Hospital

Investigators

  • Study Chair: Meng Jiang, MD, RenJi Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
RenJi Hospital
ClinicalTrials.gov Identifier:
NCT04664387
Other Study ID Numbers:
  • SSSCN202010
First Posted:
Dec 11, 2020
Last Update Posted:
Apr 8, 2021
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by RenJi Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2021